Our previous studies have revealed that iptakalim could alleviate pulmonary artery remodeling and pulmonary hypertension in chronic hypoxic rats and inhibit the proliferation of rabbit or human PASMCs induced by endothelin-1 (ET-1)[23]–[25]. The gene discussed is EDN1; the disease is pulmonary arterial hypertension.